Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
U.S. Commerce Secretary Howard Lutnick announces completed trade deal with unnamed country, approval pending.
Hilton reports strong Q1 2025 results, boosts full-year guidance and expands hotel portfolio.
Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
U.S. Commerce Secretary Howard Lutnick announces completed trade deal with unnamed country, approval pending.
Hilton reports strong Q1 2025 results, boosts full-year guidance and expands hotel portfolio.